The qualitative and quantitative analysis of an antibiotic drug, 5-amino-1 cyclopropyl-7 (cis-3, 5 dimethyl-l-piperazyl)-6,8-dihydro-1, 4 dihydroo4-oxo-3-quinoline carboxylic acid (Sparfloxacin, SFX) and its pharmaceutical formulation i.e.sparx-100 tablet, has been done using polarographic and amperometric methods. Complexation behavior of SFX with Fe(II), both in solid and liquid phases has been studied by elemental analysis, IR.-spectra and polarographic and amperometric methods. SFX produces a single cathodic reduction wave in 0.1 M ammonium tartrate (supporting electrolyte) at pH 6.0 .+-0.1. The wave is diffusion controlled and wave height is proportional to the concentration of SFX. The complex is also reversibly reduced at the electrode surface with diffusion-controlled kinetics. The stoichiometry of the Fe(II)-SFX complex is 1:1. Antibacterial studies on the drug and its metal complex have been performed against different bacteria. The observed results revealed the complex to be more potent in its antibacterial activity as compared to the parent drug. On the basis of observed results it could be concluded that the prepared Fe(II)-SFX complex may be recommended to the therapeutic experts for its possible use as a more potent antibiotic drug.
INTRODUCTION
SFX, 5-amino-cyclopropyl-7 (cis-3,5 dimethyl-l-piperazyl)-6,8-dihydro-1, 4 dihydro-4-oxo-3-quinoline carboxylic acid (an antibiotic drug) is used for the treatment of many diseases such as tuberculosis, skin diseases, etc.
Iron(II) plays a very important role in biological systems. It is an established fact that the oxygen transport in-vivo takes place through th iron complex i..hmoglobin. Several other important roles of irons are also well known. The biochemical, pharmacological and medicinal importance of metal-drug complexes is very well established /1,4/. In continuation to the work done in our laboratory on the studies of electrochemical, bioinorganic, antibacterial and pharmacological behavior of some metal-drug complexes/5,6/the present paper discusses the role of biomtal ion Fe(ll) in the physicochemieal and bioinorganie behavior of SFX and deals with the said studies on th F(II)-SFX complex. The analysis of SFX in pharmaceutical formulation i.e. sparx-100 (tablet) was performed by dissolving the tablet in 100 ml of water alcohol (45:55 v/v) and following the earlier discussed polarographic and amperometric procedures.
EXPERIMENTAL

Preparation of Complex
For the study of stoichiometry and formation constant of the complex, Lingane's polarographic method was used. Experimental sets were prepared by keeping overall iron (metal ion) and potassium chloride concentration fixed at lmM and 0.1M respectively. The ligand concentration was varied from 0.0 to 15 raM.
The pH of the test solution was adjusted to 5.0. The solution was deaerated with purified H2 gas. Polarograms were recorded keeping the initial potential set to -1.1 volts.
The amperometric titrations were performed on a manually operated set-up equipped with a polyflex galvanometer (sensitivity 8.1.10-9) and an Ajco vamier potentiometer. DME was used as an indicator electrod a,d a calomel electrode served as reference electrode. The capillary characteristic of the DME had a m2/3, u6 value of 2.13 mg 2/3 sec -/2 at 60cm effective height of mercury column, pH measurements were made on a Systronics pH meter model 335 using a glass and a calomel electrode. All the measurements were made at 25 C.
The experimental sets were prepared by taking different but known amounts of Fe(II) in the cell to which an appropriate amount of KCI (supporting electrolyte ) was added to make its overall concentration 0.1M. The pH was then adjusted to 5.0; it was then titrated against the standard solution of SFX (pH 5.0) at -1.6 V vs saturated calomel electrode (the plateau potential of Fe(II)). After each addition of the titrant the current was read on the galvanometer and the current versus volume of titrant added was plotted.
Synthesis of the Solid Complex
A brown coloured solid complex was synthesized by refluxing the 1:1 aqueous solution of ferrous ammonium sulphate and SFX solution in water and ethyl alcohol (55:45v/v) for about 5 hr. The conplexation was marked by precipitation after reducing the volume of reaction mixture to one fourth of the original volume .The product was filtered, washed, dried over P40!0 and stored.
The results of elemental (C, H, N and O) analysis on the drug and its Fe(II)-SFX were furnished by the CDRI, Lucknow, India. The complexometric method was used for the estfination of iron in the complex/8/.
Biological Study of Fe(ll) SFX Complex
Biochemical applications are in demand nowadays. The activity of bacteria on several compounds gives more important information about the complex. So it prompted us to screen the complex and precursors to find out which part of the molecule is actually responsible for its physiological activity.
Antibacterial Studies
Raper's paper disc method/9/was followed for the antibacterial screening of Fe(II)-SFX complex against some pathogenic bacteria, viz. Staphylococcus aureus, Salmonella typhi, Basillus subtalis and Escheria coli. The percentage inhibition was calculated using the following formula/9/. l'ol. 9 
where 'a' represents the diameter of zone of inhibition for control and 'b' for the complex.
RESULTS AND DISCUSSION
SFX produced a well defined polarographic wave/peak in 0.1M ammonium tartrate pH 6.0+0.1 with E , --1.45, Ep---1.49 V vs SCE. Its wave height was found to be proportional to the concentration of SFX (Fig   and 2) . The polarographic analysis of SFX in the pharmaceutical formulation sparx-100, tablet revealed 100rag SFX per tablet, which is in good agreement with that claimed by the manufacturer. 
Polarographic Study of M" L Complexation Equilibrium
Both Fe(ll) and its complex with SFX ligand produce a reversible two-electron reduction wave in 0.1M KCI at pH 5.0. The number of electrons involved in the electrode reaction was confirmed by the plots of log (i/id-i) VS E. The plot of ia vs /h co.-. proved the reduction to be diffusion-controlled.
The complex formation between Fe(ll) and SFX (Fig. 3) was revealed by the shift in half-wave potential of Fe(ll) metal ion to a more elect,'onegative value and decrease in the height of the diffusion current with gradual increase of the SFX concentration.
Plots of A E/2 (shift in the E/2) (E/2)c-(E /2) against log C (logarithm of the concentration of the ligand) realted in a linear plot. The linear plot showed the formation of single complex species in solution. Lingane/I 1/treatment of the observed polarographic data revealed I:IFe(II)-SFX complex formation with formation constant log 3-3.9 (Fig. 4) . R R N T Fe(ll) gives a well defined polarographic wave in 0.1M KCI at pH 5.0 + 0.1. The diffusion current was found proportional to its concentration. The SFX does not produce any wave under the said experimental condition. The plateau potential for the polarographic wave of Fe(II), 1.6 V vs Hg pool anode was applied for carrying out amperometric titration. Fe (11) was taken as titrate, and the drug solution was taken as titrant. The current volume plots resulted in an L shaped curve (Fig. 5) . The end point as located by a graphic method revealed a metal to drug ratio of I:1, which is in agreement with the author's observation on the metal:ligand complexation equilibrium using a polarographic method. 
Elemental Analysis
The results of elemental analysis on the drug and its complex with Fe(II) are depicted in Table 1 . The table revealed a 1"1 metal:drug ratio in the complex, which supports the author's finding using polarographic and amperometric methods.
IR-Spectra
Some important frequencies of IR signals of SFX and its Fe(ll) complex are listed in Table 2 . The stretching vibration due to (C=O) and (N-H) in the IR spectrum of the drug appear as a band at 1710 cm "1 and a doublet between 3300-3450 cm " /12,13/ and are shifted as a band at 1700 cm " and as a broad and reduced band at 3150 cm " respectively, in the spectrum of Fe(II)-SFX complex. Thus, it could be concluded that oxygen of carboxylic acid and nitrogen of N-H group are involved in complex formation with the metal ion.
,S''ati .hlin eta/.
Antibacterial Studies
Antibacterial activity of the compound (0.5M Conc.) is depicted in Table 3 showing the various bacteria. This complex was found to be more toxic against bacteria. In the case of Basillus subtalis, Salmonella typhi, Escheria coli and Staphylococcus aureus, the percentage inhibition due to Fe(II)-SFX complex is -18.0, 16.6, 15.7 and 13.6 respectively over the parent drug control. Including diameter of filter paper disc 6 mm Drug Drug-metal complex mg/ml (equivalent mg/ml)
CONCLUSION
The polarographic/amperometric methods could be successfully used for the qualitative and quantitative analysis of SFX in pharmaceutical formulation, i.e. sparx-100, and could be recommended for its use for quality control purposes in the drug industry. In addition, in view of the increased bacterial potency it may be recommended to the therapeutic experts for its possible use as a more potent antibiotic drug.
